BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19589334)

  • 1. Spinal ERK activation via NO-cGMP pathway contributes to nociceptive behavior induced by morphine-3-glucuronide.
    Komatsu T; Sakurada S; Kohno K; Shiohira H; Katsuyama S; Sakurada C; Tsuzuki M; Sakurada T
    Biochem Pharmacol; 2009 Oct; 78(8):1026-34. PubMed ID: 19589334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice.
    Komatsu T; Sakurada S; Katsuyama S; Sanai K; Sakurada T
    Int Rev Neurobiol; 2009; 85():207-19. PubMed ID: 19607972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord.
    Komatsu T; Katsuyama S; Nagase H; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Pharmacol Biochem Behav; 2016 Jan; 140():68-74. PubMed ID: 26476133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular signal-regulated kinase (ERK) and nitric oxide synthase mediate intrathecal morphine-induced nociceptive behavior.
    Komatsu T; Sakurada C; Sasaki M; Sanai K; Tsuzuki M; Bagetta G; Sakurada S; Sakurada T
    Neuropharmacology; 2007 Apr; 52(5):1237-43. PubMed ID: 17353023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal ERK2 activation through δ2-opioid receptors contributes to nociceptive behavior induced by intrathecal injection of leucine-enkephalin.
    Komatsu T; Katsuyama S; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2014 Apr; 54():131-9. PubMed ID: 24480726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of Supplementary Analgesics Capable of Reducing the Dosage of Morphine].
    Komatsu T
    Yakugaku Zasshi; 2016; 136(2):329-35. PubMed ID: 26831810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ERK phosphorylation by substance P N-terminal fragment decreases capsaicin-induced nociceptive response.
    Komatsu T; Mizoguchi H; Sasaki M; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Neuropharmacology; 2011 Sep; 61(4):608-13. PubMed ID: 21601581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Furuta S; Sato T; Satoh S; Yasuhara H; Tadano T
    J Pharmacol Sci; 2007 May; 104(1):39-45. PubMed ID: 17452810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
    Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cannabinoid 1 receptor antagonist AM251 produces nocifensive behavior via activation of ERK signaling pathway.
    Katsuyama S; Mizoguchi H; Komatsu T; Nagaoka K; Sakurada S; Sakurada T
    Neuropharmacology; 2010 Nov; 59(6):534-41. PubMed ID: 20654633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal substance P (1-7) prevents morphine-evoked spontaneous pain behavior via spinal NMDA-NO cascade.
    Sakurada T; Komatsu T; Kuwahata H; Watanabe C; Orito T; Sakurada C; Tsuzuki M; Sakurada S
    Biochem Pharmacol; 2007 Sep; 74(5):758-67. PubMed ID: 17658485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of intrathecally administered hemokinin-1-induced nociceptive behaviors in mice.
    Watanabe C; Mizoguchi H; Yonezawa A; Sakurada S
    Peptides; 2010 Aug; 31(8):1613-6. PubMed ID: 20451571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
    Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of spinal N-methyl-D-aspartate receptors stimulates a nitric oxide/cyclic guanosine 3,5-monophosphate/glutamate release cascade in nociceptive signaling.
    Kawamata T; Omote K
    Anesthesiology; 1999 Nov; 91(5):1415-24. PubMed ID: 10551594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of spinal ERK signaling pathway contributes to pain-related responses induced by scorpion Buthus martensi Karch venom.
    Pang XY; Liu T; Jiang F; Ji YH
    Toxicon; 2008 May; 51(6):994-1007. PubMed ID: 18328523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.
    Sakurada T; Katsuyama S; Sakurada S; Inoue M; Tan-No K; Kisara K; Sakurada C; Ueda H; Sasaki J
    Br J Pharmacol; 1999 Aug; 127(7):1712-8. PubMed ID: 10455330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of nociception evoked by intrathecal high-dose morphine.
    Sakurada T; Komatsu T; Sakurada S
    Neurotoxicology; 2005 Oct; 26(5):801-9. PubMed ID: 15936820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
    Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
    Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
    Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
    Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
    Yoshida A; Mobarakeh JI; Sakurai E; Sakurada S; Orito T; Kuramasu A; Kato M; Yanai K
    Eur J Pharmacol; 2005 Oct; 522(1-3):55-62. PubMed ID: 16212954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.